167 related articles for article (PubMed ID: 16138225)
1. The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic hemodialysis.
Randon RB; Rohde LE; Comerlato L; Ribeiro JP; Manfro RC
Braz J Med Biol Res; 2005 Sep; 38(9):1409-16. PubMed ID: 16138225
[TBL] [Abstract][Full Text] [Related]
2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
3. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
Wanic-Kossowska M; Lehmann P; Czekalski S
Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
[TBL] [Abstract][Full Text] [Related]
4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
[TBL] [Abstract][Full Text] [Related]
5. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
[TBL] [Abstract][Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
7. [Left ventricular systolic and diastolic dysfunction in patients with chronic renal failure treated with hemodialysis].
Wanic-Kossowska M; Lehmann P; Czekalski S
Pol Arch Med Wewn; 2003 Apr; 109(4):365-73. PubMed ID: 12931488
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. [Parathormone and left ventricular hypertrophy].
Massimetti C; Achilli P; Zampi G; Feriozzi S
G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504162
[TBL] [Abstract][Full Text] [Related]
10. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients.
Fujii H; Kim JI; Abe T; Umezu M; Fukagawa M
Intern Med; 2007; 46(18):1507-12. PubMed ID: 17878635
[TBL] [Abstract][Full Text] [Related]
11. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.
Mitsnefes MM; Daniels SR; Schwartz SM; Meyer RA; Khoury P; Strife CF
Pediatr Nephrol; 2000 Sep; 14(10-11):898-902. PubMed ID: 10975295
[TBL] [Abstract][Full Text] [Related]
12. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
[TBL] [Abstract][Full Text] [Related]
13. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
[TBL] [Abstract][Full Text] [Related]
14. Impact of secondary hyperparathyroidism on ventricular mass regression after aortic valve replacement for aortic stenosis in hemodialysis-dependent patients.
Takami Y; Tajima K
Heart Vessels; 2015 Jul; 30(4):510-5. PubMed ID: 24760625
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
Savage T; Giles M; Tomson CV; Raine AE
Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
[TBL] [Abstract][Full Text] [Related]
16. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography.
Chang ST; Chen CC; Chen CL; Cheng HW; Chung CM; Yang TY
Blood Purif; 2004; 22(4):351-9. PubMed ID: 15297785
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
[TBL] [Abstract][Full Text] [Related]
18. Effects of secondary hyperparathyroidism on cardiac function in pediatric patients on hemodialysis.
Beşbaş N; Saatçi U; Ozkutlu S; Bakkaloğlu A; Söylemezoğlu O; Ozen S
Turk J Pediatr; 1995; 37(4):299-304. PubMed ID: 8560596
[TBL] [Abstract][Full Text] [Related]
19. Changes in left ventricular mass in children and adolescents during chronic dialysis.
Mitsnefes MM; Daniels SR; Schwartz SM; Khoury P; Strife CF
Pediatr Nephrol; 2001 Apr; 16(4):318-23. PubMed ID: 11354774
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
Hsu HJ; Wu MS
Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
